Concepedia
Statistics
Publications
40
Citations
2K
H-Index
25
Active since
1996
Affiliations
Pfizer (United States)(Current)
University of California, Santa Cruz
Scripps Research Institute
University of California, San Francisco
Foton Motors (China)
Chris Limberakis is an author at Pfizer (United States) specializing in drug discovery, medicinal chemistry, and pharmacology.
Publications per year
1996–2023
A class of selective antibacterials derived from a protein kinase inhibitor pharmacophore
J. Richard Miller, Steve Dunham, Igor Mochalkin et al. · Proceedings of the National Academy of Sciences · 2009 · 160 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +17
Nonclassical Size Dependence of Permeation Defines Bounds for Passive Adsorption of Large Drug Molecules
Cameron R. Pye, William M. Hewitt, Joshua Schwochert et al. · Journal of Medicinal Chemistry · 2017 · 156 citations · Full text
A Small-Molecule Oral Agonist of the Human Glucagon-like Peptide-1 Receptor
David A. Griffith, David J. Edmonds, Jean‐Philippe Fortin et al. · Journal of Medicinal Chemistry · 2022 · 153 citations · Full text
Medicine, Endocrinology, Pharmacology +17
Optimizing PK properties of cyclic peptides: the effect of side chain substitutions on permeability and clearance
Arthur C Rand, Siegfried S. F. Leung, Heather Eng et al. · MedChemComm · 2012 · 131 citations
Pharmacy, Pharmacokinetics, Pharmacology +17
Peptidic macrocyclization via palladium-catalyzed chemoselective indole C-2 arylation
Huijun Dong, Chris Limberakis, Spiros Liras et al. · Chemical Communications · 2012 · 112 citations
Natural Sciences, Chemistry, Medicinal Chemistry +17
1–5 of 40